General Information of Drug (ID:
DR3063) |
Drug Name |
Galocitabine
|
Synonyms |
Galocitabine; Ro-09-1390; N-[1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydro-4-pyrimidinyl]-3,4,5-trimethoxybenzamide; 5'-Deoxy-5-fluoro-N4-(3,4,5-trimethoxybenzoyl)cytidine |
Indication |
Solid tumour/cancer
[ICD11: 2A00-2F9Z]
|
Discontinued in Phase 3
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
439.4 |
Topological Polar Surface Area |
139 |
Heavy Atom Count |
31 |
Rotatable Bond Count |
6 |
Hydrogen Bond Donor Count |
3 |
Hydrogen Bond Acceptor Count |
9 |
Cross-matching ID |
- PubChem CID
- 65950
- CAS Number
-
- TTD Drug ID
- D0Y4AZ
- Formula
- C19H22FN3O8
- Canonical SMILES
- C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=NC2=O)NC(=O)C3=CC(=C(C(=C3)OC)OC)OC)F)O)O
- InChI
- InChI=1S/C19H22FN3O8/c1-8-13(24)14(25)18(31-8)23-7-10(20)16(22-19(23)27)21-17(26)9-5-11(28-2)15(30-4)12(6-9)29-3/h5-8,13-14,18,24-25H,1-4H3,(H,21,22,26,27)/t8-,13-,14-,18-/m1/s1
- InChIKey
- TVYPSLDUBVTDIS-FUOMVGGVSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.